AstraZeneca safety controversy, shipping issues

Primary tabs

AstraZeneca safety controversy, shipping issues

Fri, 2021-03-12 09:16 — mike kraft

Covid 19 live updates: WHO says no link between blood clots and AstraZeneca vaccine as more nations suspend its use Italy, Romania and Thailand joined at least four other European nations this week in suspending the injections while the bloc’s drug regulator investigates. Erin Cunningham, Lateshia Beachum Washington Post

The World Health Organization Friday said that there was no reason to stop using the Oxford-AstraZeneca coronavirus vaccine, as a growing number of countries in Europe and elsewhere have moved to halt its use over blood clot concerns.

Italy, Romania and Thailand joined at least eight European nations this week in suspending the injections either from specific batches or as part of a total freeze, citing the potential adverse events despite a lack of formal evidence that the shot is unsafe.

A WHO spokeswoman, Margaret Harris, told a briefing Friday that an expert advisory committee was investigating the reports of individuals falling ill or dying after developing blood clots in the post-vaccination period, but that no causal link had been established.

ALSO SEE: AstraZeneca cuts EU vaccine supply again; health bodies dismiss safety fears

AND: "No evidence" of blood clot risk from vaccine, AstraZeneca says

AND: Tens of millions of doses from AstraZeneca are waiting for US trial results, while countries that authorized the vaccine beg to have them. --NY Times

Country / Region Tags:

General Topic Tags: